4164 Chengye Medical: Announces Shareholder Dividend Distribution by Key Subsidiary Fu Kang Active Pharmaceutical Co., Ltd.
Key facts
- 4164 Chengye Medical: Announces Shareholder Dividend Distribution by Key Subsidiary Fu Kang Active Pharmaceutical Co., Ltd.
- Chengye Medical announces that its key subsidiary, Fu Kang Active Pharmaceutical Co., Ltd., has resolved to distribute a cash dividend of TWD 77,475,270 following a shareholder meeting resolution, reflecting stable profitability and shareholder returns.
- Source: PR Times
- Date: June 27, 2026
Direct answer
Chengye Medical announces that its key subsidiary, Fu Kang Active Pharmaceutical Co., Ltd., has resolved to distribute a cash dividend of TWD 77,475,270 following a shareholder meeting resolution, reflecting stable profitability and shareholder returns.
- Citation
- 4164 Chengye Medical: Announces Shareholder Dividend Distribution by Key Subsidiary Fu Kang Active Pharmaceutical Co., Ltd. (June 27, 2026), PR Times
- Source
- PR Times
- Date
- June 27, 2026
Chengye Medical announces that its key subsidiary, Fu Kang Active Pharmaceutical Co., Ltd., has resolved to distribute a cash dividend of TWD 77,475,270 following a shareholder meeting resolution, reflecting stable profitability and shareholder returns.
📋 Article Processing Timeline
- 📰 Published: June 27, 2026 at 09:00
- 🔍 Collected: June 27, 2026 at 15:23 (6h 23m after Published)
- 🤖 AI Analyzed: June 27, 2026 at 15:25 (1 min after Collected)
Announcement Date: June 27, 2026
Statement Date: June 26, 2026
Statement Time: 16:24:52
Company Code: 4164
Company Name: Chengye Medical
Subject: Announcement of Dividend Distribution Resolved by Shareholders' Meeting of Key Subsidiary Fu Kang Active Pharmaceutical Co., Ltd.
Applicable Clause: Item 14
Event Date: June 26, 2026
Details:
1. Board Resolution Date: June 26, 2026
2. Type and Amount of Dividend Distribution:
Cash dividend of TWD 77,475,270.
3. Other Matters to be Disclosed: None
Statement Date: June 26, 2026
Statement Time: 16:24:52
Company Code: 4164
Company Name: Chengye Medical
Subject: Announcement of Dividend Distribution Resolved by Shareholders' Meeting of Key Subsidiary Fu Kang Active Pharmaceutical Co., Ltd.
Applicable Clause: Item 14
Event Date: June 26, 2026
Details:
1. Board Resolution Date: June 26, 2026
2. Type and Amount of Dividend Distribution:
Cash dividend of TWD 77,475,270.
3. Other Matters to be Disclosed: None
FAQ
What is Chengye Medical?
A Taiwan-based healthcare company operating through subsidiaries in pharmaceuticals and wellness.
When will the dividend be paid?
The payment date has not been announced, but typically occurs within 1–2 months after resolution.
What does Fu Kang Active Pharmaceutical do?
It focuses on pharmaceutical development and distribution in Taiwan’s domestic market.
Does this announcement affect investment decisions?
Stable dividends signal financial health, making it a positive indicator for long-term investors.
Where is Chengye Medical listed?
It is listed on the Taiwan Stock Exchange under ticker 4164.